ADJACENT TREATMENT

Tadalafil

A PDE5-inhibitor medication with approved product contexts; compounded and combination formulations require their own product-level review.

Record boundary

Type: Small-molecule medication
Category: Sexual Health
Status: Editorial review pending

On this page

01 / CLASSIFICATION

Not every wellness-market record is a peptide.

Tadalafil is included because it appears in the source inventory, but it is classified as small-molecule medication. This prevents search coverage from distorting the underlying science.

Coverage is not endorsement

This page confirms that the item exists in the coverage graph. It does not recommend use or repeat commercial benefit claims.

02 / SOURCES

Inspect the record trail.

IDENTITY SOURCEPubChem compound record

Primary or authoritative identity record

COVERAGE SOURCEBB Health+ tadalafil page

Source inventory reviewed August 8, 2026

03 / REVIEW BOUNDARY

What is still intentionally unresolved.

Evidence

No evidence score is shown until human and preclinical sources are reviewed separately.

Status

No approval, compounding, or anti-doping statement is inherited from a related ingredient without review.